LINC00029

Across TCGA pan-cancer cohorts, LINC00029 mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated LINC00029 data layer compared with 17 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LINC00029 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC00029 expression acts as an unfavorable survival marker.

HNSC are the cancer types where LINC00029 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	All	0.407	0.954	.006	44	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

LINC00029–HNSC (DFS)

Open the HNSC breakdown →